Detalles de la búsqueda
1.
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.
Blood
; 116(17): 3227-37, 2010 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-20651070
2.
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
Blood
; 115(25): 5202-13, 2010 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20382844
3.
CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumorigenicity via c-maf-mediated interactions with bone marrow stromal cells.
Blood
; 113(18): 4309-18, 2009 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19196658
4.
Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma.
Haematologica
; 96(8): 1170-9, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21712538
5.
Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo.
Br J Haematol
; 149(4): 537-49, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20331454
6.
Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
PLoS One
; 12(8): e0182855, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28854237
7.
Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
Clin Cancer Res
; 22(16): 4259-70, 2016 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27169995
Resultados
1 -
7
de 7
1
Próxima >
>>